Patents by Inventor Osigwe Esue

Osigwe Esue has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods for stabilizing protein-containing formulations
    Patent number: 11938189
    Abstract: The present invention relates to use of certain alkylglycoside compositions for the prevention of aggregation and oxidation of antibodies and other proteins in therapeutically useful formulations thereof.
    Type: Grant
    Filed: July 27, 2021
    Date of Patent: March 26, 2024
    Assignee: Genentech, Inc
    Inventors: Osigwe Esue, Vikas K. Sharma
  • COMPOSITIONS AND METHODS FOR STABILIZING PROTEIN-CONTAINING FORMULATIONS
    Publication number: 20210353756
    Abstract: The present invention relates to use of certain alkylglycoside compositions for the prevention of aggregation and oxidation of antibodies and other proteins in therapeutically useful formulations thereof.
    Type: Application
    Filed: July 27, 2021
    Publication date: November 18, 2021
    Applicant: Genentech, Inc.
    Inventors: Osigwe Esue, Vikas K. Sharma
  • Compositions and methods for stabilizing protein-containing formulations
    Patent number: 11103584
    Abstract: The present invention relates to use of certain alkylglycoside compositions for the prevention of aggregation and oxidation of antibodies and other proteins in therapeutically useful formulations thereof.
    Type: Grant
    Filed: December 10, 2018
    Date of Patent: August 31, 2021
    Assignee: GENENTECH, INC.
    Inventors: Osigwe Esue, Vikas K. Sharma
  • COMPOSITIONS AND METHODS FOR STABILIZING PROTEIN-CONTAINING FORMULATIONS
    Publication number: 20190216929
    Abstract: The present invention relates to use of certain alkylglycoside compositions for the prevention of aggregation and oxidation of antibodies and other proteins in therapeutically useful formulations thereof.
    Type: Application
    Filed: December 10, 2018
    Publication date: July 18, 2019
    Applicant: Genentech, Inc.
    Inventors: Osigwe Esue, Vikas K. Sharma
  • Compositions and methods for stabilizing protein-containing formulations
    Patent number: 10188735
    Abstract: The present invention relates to use of certain alkylglycoside compositions for the prevention of aggregation and oxidation of antibodies and other proteins in therapeutically useful formulations thereof.
    Type: Grant
    Filed: December 11, 2015
    Date of Patent: January 29, 2019
    Assignee: GENENTECH, INC.
    Inventors: Osigwe Esue, Vikas K. Sharma
  • COMPOSITIONS AND METHODS FOR STABILIZING PROTEIN-CONTAINING FORMULATIONS
    Publication number: 20160199494
    Abstract: The present invention relates to use of certain alkylglycoside compositions for the prevention of aggregation and oxidation of antibodies and other proteins in therapeutically useful formulations thereof.
    Type: Application
    Filed: December 11, 2015
    Publication date: July 14, 2016
    Applicant: Genentech, Inc.
    Inventors: Osigwe Esue, Vikas K. Sharma
  • Compositions and methods for stabilizing protein-containing formulations
    Patent number: 9254321
    Abstract: The present invention relates to use of certain alkylglycoside compositions for the prevention of aggregation and oxidation of antibodies and other proteins in therapeutically useful formulations thereof.
    Type: Grant
    Filed: December 20, 2012
    Date of Patent: February 9, 2016
    Assignee: Genentech, Inc.
    Inventors: Osigwe Esue, Vikas K. Sharma
  • Anti-oxidized LDL antibody formulation
    Patent number: 8318161
    Abstract: A formulation comprising a therapeutically effective amount of an antibody, optionally, not subjected to prior lyophilization, a buffer maintaining the pH in the range from about 4.5 to about 6.5, and an optional surfactant is described, along with uses for such a formulation.
    Type: Grant
    Filed: March 5, 2010
    Date of Patent: November 27, 2012
    Assignee: Genentech, Inc.
    Inventor: Osigwe Esue
  • Antibody Formulation
    Publication number: 20100239567
    Abstract: A formulation comprising a therapeutically effective amount of an antibody, optionally, not subjected to prior lyophilization, a buffer maintaining the pH in the range from about 4.5 to about 6.5, and an optional surfactant is described, along with uses for such a formulation.
    Type: Application
    Filed: March 5, 2010
    Publication date: September 23, 2010
    Applicant: Genentech, Inc.
    Inventor: Osigwe Esue